Glympse Bio, Inc.
Injectable diagnostic test using activity-based probes and nanosensors that detect HCC-specific protease activity in urine via mass spectrometry
- Sector
- Medtech
- Headquarters
- Cambridge, MA
- Total capital
- $5.2M
- Federal grants
- $5.2M
- 7 awards · 2017–2021
- Rank in peer group#150 of 538
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 36 pending · first 2021
- Rank in peer group#125 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Early detection of HCC using noninvasive activity-based nanosensors$964K
- Federal grantHealth and Human S · Phase II · Early detection of HCC using noninvasive activity-based nanosensors$2M
- Federal grantHealth and Human S · Phase II · Early detection of HCC using noninvasive activity-based nanosensors$291K
- Federal grantHealth and Human S · Phase II · Noninvasive urinary monitoring of NASH by activity-based nanosensors$923K
- Federal grantHealth and Human S · Phase II · Noninvasive urinary monitoring of NASH by activity-based nanosensors$556K
- Federal grantHealth and Human S · Phase I · Noninvasive urinary monitoring of NASH by activity based nanosensors$225K
- Federal grantHealth and Human S · Phase II · Noninvasive urinary monitoring of NASH by activity-based nanosensors$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#150 · top 28%
- Granted patents#125 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Amy Roopom SchulmanDirectorNamed in SEC Form D filings
- Caroline LoewExecutive Officer, DirectorNamed in SEC Form D filings
- Dhaval Winckler GosaliaExecutive OfficerNamed in SEC Form D filings
- Francis CussDirectorNamed in SEC Form D filings
- Gabriel KwongExecutive OfficerNamed in SEC Form D filings
- George ZacharyDirectorNamed in SEC Form D filings
Show all 18 people
- Jessica Winckler AtkinsonExecutive OfficerNamed in SEC Form D filings
- Matthew Winckler NavarroExecutive OfficerNamed in SEC Form D filings
- Robert LangerDirectorNamed in SEC Form D filings
- Sirshendu Roopom BanerjeeExecutive OfficerNamed in SEC Form D filings
- Stan Roopom LapidusDirectorNamed in SEC Form D filings
- Stanley LapidusDirectorNamed in SEC Form D filings
- Steve KafkaDirectorNamed in SEC Form D filings
- Theresia GouwDirectorNamed in SEC Form D filings
- Theresia Roopom GuowDirectorNamed in SEC Form D filings
- Tracey DawsonExecutive OfficerNamed in SEC Form D filings
- Tram Winckler TranExecutive OfficerNamed in SEC Form D filings
- Wendy Winckler AdamovichExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 40- GrantedEx Vivo Protease Activity Detection For Disease Detection/diagnostic, Staging, Monitoring And TreatmentUSPTOUS 11,851,697
- GrantedActivity Sensor With Tunable AnalyteUSPTOUS 11,732,009
- GrantedEx Vivo Protease Activity Detection For Disease Detection/diagnostic, Staging, Monitoring And TreatmentUSPTOUS 11,604,193
Show all 40 patent records
- Ex Vivo Protease Activity Detection For Disease Detection/diagnostic, Staging, Monitoring And TreatmentDec 26, 2023 · US 11,851,697Granted
- Activity Sensor With Tunable AnalyteAug 22, 2023 · US 11,732,009Granted
- Ex Vivo Protease Activity Detection For Disease Detection/diagnostic, Staging, Monitoring And TreatmentMar 14, 2023 · US 11,604,193Granted
- Multi-factor Activity MonitoringOct 28, 2021 · Application 17238593Pending
- Cancer-related Activity SensorsOct 28, 2021 · Application 17238585Pending
- Activity Sensor ControlsOct 28, 2021 · Application 17238599Pending
- Diagnosis And Monitoring Of Liver DiseaseJun 8, 2021 · US 11,028,425Granted
- Detecting Architectural Remodelling In Cells, Extracellular Matrix, And The Tissue MicroenvironmentAug 6, 2020 · Application 16777025Pending
- Compositions And Methods For Monitoring Progression And Regression Of Disease In Patients In Response To TherapyAug 6, 2020 · Application 16355110Pending
- Bodily Processing Of Activity SensorsAug 6, 2020 · Application 16776991Pending
- Activity Sensor DesignDec 12, 2019 · Application 16434785Pending
- Engineered Cyclic PeptidesDec 12, 2019 · Application 16435350Pending
- Engineered Cyclic PeptidesDec 12, 2019 · Application 16435151Pending
- Cancer-related Activity SensorsApplication PCTUS2021028794Pending
- Ex Vivo Detection Of Pathogens In Body Fluid SamplesApplication 63132776Pending
- Ex Vivo Protease Activity DetectionApplication 63077525Pending
- Activity Sensor ControlsApplication 63015341Pending
- Cancer-related Activity SensorsApplication 63015340Pending
- Multi-factor Activity MonitoringApplication 63015342Pending
- Bodily Processing Of Activity SensorsApplication PCTUS2020015823Pending
- Detecting Architectural Remodelling In Cells Extracellular Matrix, And The Tissue MicroenvironmentApplication PCTUS2020015828Pending
- Compositions And Methods For Monitoring Progression And Regression Of Disease In Patients In Response To TherapyApplication PCTUS2020015831Pending
- Diagnosis And Monitoring Of Liver DiseaseApplication PCTUS2019036039Pending
- Activity Sensor With Tunable AnalyteApplication PCTUS2019036036Pending
- Engineered Cyclic PeptidesApplication PCTUS2019036155Pending
- Engineered Cyclic PeptidesApplication PCTUS2019036119Pending
- Activity Sensor DesignApplication PCTUS2019036041Pending
- Bodily Processing Of Activity SensorsApplication 62800107Pending
- Detecting Architectural Remodelling In Cells, Extracellular Matrix, And The Tissue MicroenvironmentApplication 62800100Pending
- Compositions And Methods For Monitoring Progression And Regression Of Disease In Patients In Response To TherapyApplication 62800089Pending
- Activity Sensor With Tunable AnalyteApplication 62682492Pending
- Diagnosis And Monitoring Of Liver DiseaseApplication 62682505Pending
- Fluorogenic Substrates For Aminopeptidase Detection In BiofluidsApplication PCTUS2023014844Pending
- Activity Sensor DesignApplication 62682507Pending
- Ex Vivo Protease Activity Detection For Hepatocellular CarcinomaApplication 63331515Pending
- Disease Detection With Combinatorial BiomakersApplication 63331520Pending
- Ex Vivo Protease Activity Detection For Hepatocellular CarcinomaApplication 63325249Pending
- Fluorogenic Substrates For Aminopeptidase Detection In BiofluidsApplication 63318141Pending
- Method Of Protease DetectionApplication 63318220Pending
- Ex Vivo Detection Of Pathogens In Body Fluid SamplesApplication PCTUS2021065529Pending
Related companies, and why
- CYION TECHNOLOGIES, LLCSimilar federal contract value in Medtech · null in contracts
- MICROMED CARDIOVASCULAR INCSimilar federal contract value in Medtech · null in contracts
- SCANOGEN INC.Similar federal contract value in Medtech · null in contracts
- Laser Tissue Welding, IncSimilar federal contract value in Medtech · null in contracts
- AXOSIM, INC.Similar federal contract value in Medtech · null in contracts
- ACIONT, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .